
    
      This is a non-randomized, prospective, single-arm, cohort study.Patients meeting the
      inclusion criteria were enrolled successively in the order of admission and treatment.In this
      study, the dose interval was set as 110-130gy, and a total of 30 patients were expected to be
      enrolled. The prescription dose was planned to be grouped into 15 patients of 110-120gy and
      120-130gy respectively. The specific situation was subject to the actual postoperative
      verification dose.
    
  